established and emerging publicly traded and select private biotech companies. February 13-14, 2017 ⢠The Waldorf Asto
CEO INVESTOR CONFERENCE
February 13-14, 2017 • The Waldorf Astoria New York
Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.
Audience Demographics 1,400+ One-on-One Meetings: 2,500+ Registered Investors: 650 Company Presentations: 190 Expert Speakers: 58
Job Profile:
86%
Attendees:
86%
86% of attendees are VP or C-Level
4%
10%
Other Director
76%
10%
C-level
VP
Companies Profile:
Breakdown by Therapeutic Focus: Diagnostics: 2%
82%
Gastrointestinal: 3%
82% of all companies attending are biopharma
Infectious Diseases: 2% Platform Discovery: 2%
Cardiovascular: 3% Regenerative Medicine: 3% Multiple: 4%
Oncology: 29%
Ophthalmology: 4%
Breakdown by Market Cap: $250M-500M: 6%
Metabolic Diseases: 4% Devices & Drug Delivery: 4%
$500M: 4%
CNS: 13% Autoimmune Inflammation: 7%
$50M-100M: 22% < $50M: 36%
Orphan/Rare Diseases: 10%
Other: 10%
$100M-250M: 32%
bio.org/CEO • #BIOCEO17
CEO INVESTOR CONFERENCE
February 13-14, 2017 • The Waldorf Astoria New York
Past Fireside Chat Speakers
Samuel D. Isaly
John F. Milligan, PhD George A. Scangos, PhD Charles E. Schumer
Managing Partner, President and Chief OrbiMed Advisors Operating Officer, Gilead Sciences
Chief Executive Officer, Biogen
United States Senator for New York (D)
Event Attributes and Opportunities ▲▲ Experience the largest, unbiased forum where
institutional investors, industry analysts, and senior biotechnology executives shape the future investment landscape of the industry. ▲▲ Hear Washington’s perspective on policy and other timely
developments affecting the industry. ▲▲ Evaluate fresh investment opportunities including
compatible, complementary, and competitive companies. ▲▲ Learn about the hottest clinical developments and
industry catalysts by attending the conference’s therapeutic workshops and business roundtables. ▲▲ Attend fireside chats with CEOs who will share their
recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2017. ▲▲ Gain access to BIO One-on-One Partnering™ for
scouting potential investments and deal partners, optimizing your time at the event. ▲▲ Unique platform for your company to highlight
accomplishments and discuss upcoming milestones. Approximately 190 companies will be chosen based on a selection process evaluating a company’s pipeline and R&D activities. ▲▲ Get the pulse of the current and proposed investment
trends in biotechnology. ▲▲ Network with peers, investors, and potential partners
Christi Shaw US Country Head, President of Novartis Corporation & President of Novartis Pharmaceuticals Corporation
Advisory Committee John Chambers, Vice-Chairman and Head of Healthcare Investment Banking, ROTH Capital Partners Barbara J. Dalton, PhD, Vice President, Venture Capital, Pfizer Inc. Linda S. Grais, MD, President and Chief Executive Officer, Ocera Therapeutics Brian Hagerty, Senior Director, Head of Healthcare Capital Markets, New York Stock Exchange Nouhad Husseini, Vice President, Business Development, Regeneron Pharmaceuticals, Inc. Michael King, Managing Director and Senior Research Analyst, JMP Securities Jonathan Leff, Partner, Deerfield Management Michael Mirsky, Managing Director, Investment Banking, H.C. Wainwright Timothy P. O’Connor, PhD, Executive Vice President, The Rockefeller University Jason Park, Principal, Flagship Ventures Dennis J. Purcell, Founder and Senior Advisor, Aisling Capital Carlo Rizzuto, PhD, Partner, Versant Ventures Matthew Roden, PhD, Vice President and Head of Strategic Corporate Development, Bristol-Myers Squibb Stephen Sands, Vice Chairman Investment Banking and Chairman Global Healthcare Group, Lazard Rajeev Shah, Managing Director & Portfolio Manager, RA Capital Nathan Tinker, PhD, Executive Director, NewYorkBIO
attending the conference and our exclusive receptions.
2
bio.org/CEO
CEO INVESTOR CONFERENCE
February 13-14, 2017 • The Waldorf Astoria New York
2016 SPONSORS Supporting Bank Sponsors
BIO Double Helix Sponsor
BIO Helix Sponsors
Conference Sponsors usedlabequipment.com
Tiberend
Strategic Advisors, Inc.
Media Partners
Local Co-Host
3
Regional Partners
bio.org/CEO
